We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$1.8B
AUM Growth
+$213M
Cap. Flow
+$72.2M
Cap. Flow %
4.02%
Top 10 Hldgs %
21.74%
Holding
131
New
18
Increased
54
Reduced
43
Closed
10

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$18.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$17.5M
4
LRCX icon
Lam Research
LRCX
+$17M
5
BOOT icon
Boot Barn
BOOT
+$16.9M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$15.5M
2
WM icon
Waste Management
WM
+$15.4M
3
OMCL icon
Omnicell
OMCL
+$14.1M
4
TRV icon
Travelers Companies
TRV
+$13.2M
5
WEX icon
WEX
WEX
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 20.28%
2 Financials 14.62%
3 Healthcare 13.69%
4 Communication Services 11.3%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
26
Danaher
DHR
$139B
$19.1M 1.06%
140,541
-16,619
-11% -$2.1M
BOOT icon
27
Boot Barn
BOOT
$5.07B
$19M 1.06%
+427,595
New +$16.9M
KMB icon
28
Kimberly-Clark
KMB
$36.5B
$18.9M 1.05%
137,044
-63
-0% -$8.52K
TGT icon
29
Target
TGT
$67.5B
$18.8M 1.05%
146,851
-7,513
-5% -$882K
TMO icon
30
Thermo Fisher Scientific
TMO
$212B
$18.7M 1.04%
57,668
-345
-0.6% -$105K
LRCX icon
31
Lam Research
LRCX
$387B
$18.7M 1.04%
+638,330
New +$17M
AXP icon
32
American Express
AXP
$235B
$18.6M 1.03%
149,372
+2,819
+2% +$337K
LULU icon
33
lululemon athletica
LULU
$14.2B
$18.6M 1.03%
80,248
-9,881
-11% -$2.11M
BSX icon
34
Boston Scientific
BSX
$71.8B
$18.2M 1.01%
403,086
+3,036
+0.8% +$127K
ALL icon
35
Allstate
ALL
$69.6B
$18.1M 1.01%
161,163
+2,658
+2% +$290K
BA icon
36
Boeing
BA
$188B
$18.1M 1.01%
55,624
+7,243
+15% +$2.56M
CVX icon
37
Chevron
CVX
$368B
$18M 1%
149,604
+7,844
+6% +$924K
BX icon
38
Blackstone
BX
$108B
$17.8M 0.99%
+318,998
New +$16.5M
ZTS icon
39
Zoetis
ZTS
$31.7B
$17.8M 0.99%
134,192
-48,464
-27% -$6.02M
CMCSA icon
40
Comcast
CMCSA
$88.3B
$17.6M 0.98%
390,970
-9,245
-2% -$412K
HD icon
41
Home Depot
HD
$349B
$17.4M 0.97%
79,890
-5,546
-6% -$1.26M
COST icon
42
Costco
COST
$419B
$17.4M 0.97%
59,137
-1,150
-2% -$342K
INTC icon
43
Intel
INTC
$510B
$17.3M 0.96%
289,425
+2,705
+0.9% +$151K
CAT icon
44
Caterpillar
CAT
$404B
$17.1M 0.95%
115,621
+24,365
+27% +$3.4M
MU icon
45
Micron Technology
MU
$1.01T
$17.1M 0.95%
317,449
+38,304
+14% +$1.83M
JBL icon
46
Jabil
JBL
$36.6B
$17.1M 0.95%
+412,702
New +$15.8M
LDOS icon
47
Leidos
LDOS
$16.6B
$17M 0.95%
174,098
-14,503
-8% -$1.28M
TFX icon
48
Teleflex
TFX
$5.77B
$17M 0.95%
45,232
-1,738
-4% -$598K
VZ icon
49
Verizon
VZ
$194B
$16.9M 0.94%
274,485
-4,385
-2% -$264K
KMI icon
50
Kinder Morgan
KMI
$69.4B
$16.8M 0.93%
793,608
+48,820
+7% +$988K

Similar funds

Braun Stacey Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Braun Stacey Associates held 131 positions worth $1.8B, up 13% from $1.58B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Braun Stacey Associates deployed $72.2M of net new capital in Q4 2019, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was CVS Health: 261,118 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Omnicell, an estimated $14.1M trimmed.

  • Braun Stacey Associates's largest Q4 2019 buy was CVS Health: 261,118 shares worth $19.4M.
  • Braun Stacey Associates added most to AT&T in Q4 2019, an estimated $8.22M increase.
  • Braun Stacey Associates's biggest Q4 2019 reduction was Omnicell, cutting an estimated $14.1M.
  • Braun Stacey Associates fully exited Cisco in Q4 2019, selling an estimated $15.5M.
  • Braun Stacey Associates's ten largest holdings make up 22% of its $1.8B portfolio in Q4 2019.
  • Braun Stacey Associates opened 18 new positions and closed 10 in Q4 2019.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $1.8B.

Based on Braun Stacey Associates's 13F filing for Q4 2019, filed 24 Jan 2020.